1 study on Pd l1 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling evidence that Thymalfasin can significantly augment the effectiveness of immune checkpoint inhibitors in patients with advanced NSCLC, leading to better response rates and prolonged surv…